55 related articles for article (PubMed ID: 12215288)
1. Role of natural killer T cells in Graves' disease.
Luo W; Guo H; Aosai F; Yano A
Chin Med J (Engl); 2002 Aug; 115(8):1183-5. PubMed ID: 12215288
[TBL] [Abstract][Full Text] [Related]
2. Induction of experimental autoimmune Graves' disease in BALB/c mice.
Kaithamana S; Fan J; Osuga Y; Liang SG; Prabhakar BS
J Immunol; 1999 Nov; 163(9):5157-64. PubMed ID: 10528222
[TBL] [Abstract][Full Text] [Related]
3. Adenovirus encoding the thyrotropin receptor A-subunit improves the efficacy of dendritic cell-induced Graves' hyperthyroidism in mice.
Mizutori Y; Saitoh O; Eguchi K; Nagayama Y
J Autoimmun; 2006 Feb; 26(1):32-6. PubMed ID: 16242303
[TBL] [Abstract][Full Text] [Related]
4. Induction of hyperthyroidism in mice by intradermal immunization with DNA encoding the thyrotropin receptor.
Barrett K; Liakata E; Rao PV; Watson PF; Weetman AP; Lymberi P; Banga JP; Carayanniotis G
Clin Exp Immunol; 2004 Jun; 136(3):413-22. PubMed ID: 15147342
[TBL] [Abstract][Full Text] [Related]
5. An improved Graves' disease model established by using in vivo electroporation exhibited long-term immunity to hyperthyroidism in BALB/c mice.
Kaneda T; Honda A; Hakozaki A; Fuse T; Muto A; Yoshida T
Endocrinology; 2007 May; 148(5):2335-44. PubMed ID: 17255207
[TBL] [Abstract][Full Text] [Related]
6. Hyperthyroxinemic mice have reduced natural killer cell activity. Evidence for a defective trigger mechanism.
Stein-Streilein J; Zakarija M; Papic M; McKenzie JM
J Immunol; 1987 Oct; 139(7):2502-7. PubMed ID: 3498760
[TBL] [Abstract][Full Text] [Related]
7. Generation of a transgenic animal model of hyperthyroid Graves' disease.
Kim-Saijo M; Akamizu T; Ikuta K; Iida Y; Ohmori K; Matsubara K; Matsuda Y; Suzuki M; Matsuda F; Nakao K
Eur J Immunol; 2003 Sep; 33(9):2531-8. PubMed ID: 12938229
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of experimental Graves' disease by intranasal administration of a T cell epitope of the thyrotropin receptor.
Arima T; Shimojo N; Yamaguchi K; Tomiita M; Kohn LD; Kohno Y
Clin Immunol; 2008 Apr; 127(1):7-13. PubMed ID: 18234558
[TBL] [Abstract][Full Text] [Related]
9. Clinical results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies.
Eckstein AK; Plicht M; Lax H; Hirche H; Quadbeck B; Mann K; Steuhl KP; Esser J; Morgenthaler NG
Clin Endocrinol (Oxf); 2004 Nov; 61(5):612-8. PubMed ID: 15521965
[TBL] [Abstract][Full Text] [Related]
10. TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre.
Wallaschofski H; Kuwert T; Lohmann T
Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):171-4. PubMed ID: 15127319
[TBL] [Abstract][Full Text] [Related]
11. The significance of immune-related molecule expression profiles in an animal model of Graves' disease.
Ye F; Hou P; Wu X; Ma X; Gao L; Wu L; Xu L; Shi B
Autoimmunity; 2012 Mar; 45(2):143-52. PubMed ID: 22017306
[TBL] [Abstract][Full Text] [Related]
12. [Immunization with targeted fusion anticaries DNA vaccine via intramuscular route:experiment with murine].
Yu F; Fan MW; Xu QA; Jia R; Guo JH; Bian Z; Chen Z; Peng B; Fan B
Zhonghua Yi Xue Za Zhi; 2004 May; 84(9):754-9. PubMed ID: 15200917
[TBL] [Abstract][Full Text] [Related]
13. Exacerbation of autoimmune thyroiditis by a single low dose of whole-body irradiation in non-obese diabetic-H2h4 mice.
Nagayama Y; Kaminoda K; Mizutori Y; Saitoh O; Abiru N
Int J Radiat Biol; 2008 Sep; 84(9):761-9. PubMed ID: 18821390
[TBL] [Abstract][Full Text] [Related]
14. An improved method for the establishment of a model of Graves' disease in BALB/c mice.
Zheng W; Wang R; Tan J; Li N; Meng Z
Mol Med Rep; 2017 Apr; 15(4):1471-1478. PubMed ID: 28259898
[TBL] [Abstract][Full Text] [Related]
15. Binding, stimulating and blocking TSH receptor antibodies to the thyrotropin receptor as predictors of relapse of Graves' disease after withdrawal of antithyroid treatment.
Quadbeck B; Hoermann R; Hahn S; Roggenbuck U; Mann K; Janssen OE
Horm Metab Res; 2005 Dec; 37(12):745-50. PubMed ID: 16372228
[TBL] [Abstract][Full Text] [Related]
16. Comparison of new different assay systems for thyrotropin receptor antibodies with reference to thyroid-stimulating antibodies and thyroid stimulation-blocking antibodies in Graves' disease.
Hirooka Y; Li C; Takagi J; Gotoh M; Habu S; Yasaka-Nomura T; Ishihara R; Nakasone Y; Nakamura R; Morikawa R; Otake K; Nogimori T; Ishizuki Y
Int J Clin Pharmacol Res; 2004; 24(4):111-6. PubMed ID: 15754915
[TBL] [Abstract][Full Text] [Related]
17. Comparison of immune responses to extracellular domains of mouse and human thyrotropin receptor.
Patibandla SA; Fan JL; Prabhakar BS; Seetharamaiah GS
J Autoimmun; 1999 Sep; 13(2):205-13. PubMed ID: 10479389
[TBL] [Abstract][Full Text] [Related]
18. Accelerated chemically induced tumor development mediated by CD4+CD25+ regulatory T cells in wild-type hosts.
Nishikawa H; Kato T; Tawara I; Takemitsu T; Saito K; Wang L; Ikarashi Y; Wakasugi H; Nakayama T; Taniguchi M; Kuribayashi K; Old LJ; Shiku H
Proc Natl Acad Sci U S A; 2005 Jun; 102(26):9253-7. PubMed ID: 15961541
[TBL] [Abstract][Full Text] [Related]
19. [Role of alloreactive natural killer cell in mouse MHC haploidentical bone marrow transplantation].
He Y; Wang HH; Wang M; Zhou Z; Zhai WJ; Huang Y; Jiang EL; Wang ZD; Zhou SY; Liu QG; Feng SZ; Han MZ
Zhonghua Xue Ye Xue Za Zhi; 2006 Feb; 27(2):82-6. PubMed ID: 16732957
[TBL] [Abstract][Full Text] [Related]
20. Absence of major histocompatibility complex class I on neural stem cells does not permit natural killer cell killing and prevents recognition by alloreactive cytotoxic T lymphocytes in vitro.
Mammolenti M; Gajavelli S; Tsoulfas P; Levy R
Stem Cells; 2004; 22(6):1101-10. PubMed ID: 15536199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
